HCs (n=21) |
HCs (n=21) |
HCs (n=21) |
Normal range |
Age, y |
|
29 (26–46) |
|
Sex |
Male |
7 (33.3%) |
|
|
Female |
14 (66.7%) |
|
AD patients (n=38) |
AD patients (n=38) |
AD patients (n=38) |
|
Age, y |
|
45.5 (20–63) |
|
Sex |
Male |
25 (65.8%) |
|
|
Female |
13 (34.2%) |
|
Disease duration, y |
|
36.0 (6–57) |
|
EASI score |
|
18.5 (1.0–54.3) |
|
Laboratory factors |
TARC (pg/mL) |
2010 (310–28604) |
<450 |
|
LDH (U/L) |
219.5 (150–486) |
124–222 |
|
Total serum IgE (IU/mL) |
6336.3 (140.8–85805.8) |
<295 |
|
Eosinophils (cells/µL) |
597.5 (15.5–3388.5) |
30–350 |
|
Basophils (cells/µL) |
61.05 (27.0–208.8) |
0–190 |
Complications |
Allergic rhinitis |
17 (45%) |
|
|
Asthma |
16 (42.1%) |
|
|
Food allergy |
11 (28.95%) |
|
|
Allergic conjunctivitis |
7 (18%) |
|
|
Urticaria |
6 (15.79%) |
|